IntelvsOptimizeRx

INTC and OPRX stock compared: price, dividend, valuation and results, from SEC filings.

INTC

Intel Corporation

$55.27

Value $294B

-7.20%
INTC's page

OPRX

OptimizeRx Corporation

$6.62

Value $124M

-9.81%
OPRX's page

Intel (INTC) has a market value of $294B and OptimizeRx (OPRX) $124M. Over the last year, with dividends, INTC moved +55.8% and OPRX -56.4%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    INTC$294B

    OPRX$124M

    INTC is 2,365 times OPRX

  • Revenue, 12 months

    INTC$59.9B

    OPRX$94M

    INTC is 636 times OPRX

  • Net income, 12 months

    INTC-$12.0B

    OPRX$5.0M

  • Operating margin

    INTC2.9%

    OPRX12.2%

    9.3 points apart

  • ROIC

    INTC0.9%

    OPRX4.6%

    3.7 points apart

  • P/E

    INTC–

    OPRX24.8

  • Dividend yield

    INTC0.0%

    OPRX0.0%

    About the same

  • 5-year return

    INTC+18.6%

    OPRX-91.7%

    110.3 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

INTC+18.6%

OPRX-91.7%

010020030020222023202420252026
Returns by period
PeriodINTCWith dividendsOPRXWith dividends
1 year since November 14, 2025+55.8%Price +55.8%-56.4%Price -56.4%
3 years since November 16, 2023+29.4%+9.0% a yearPrice +27.6%-32.9%-12.5% a yearPrice -32.9%
5 years since November 15, 2021+18.6%+3.5% a yearPrice +10.0%-91.7%-39.3% a yearPrice -91.7%
10 years since November 16, 2016+94.5%+6.9% a yearPrice +58.8%+125.2%+8.5% a yearPrice +125.2%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

INTCIntelOPRXOptimizeRx

Valuation

INTCOPRX
Valuation
Price$55.27$6.62
Market value$294B$124M
Enterprise value (EV)$290B–
P/E–24.8
P/E, 5-year median––
P/B2.60.9
EV/EBIT164.5–
Free cash flow yield1.3%16.0%

Results and growth

INTCOPRX
Results and growth
Revenue, 12 months$59.9B$94M
Net income, 12 months-$12.0B$5.0M
Free cash flow, 12 months$3.8B$20M
Earnings per share, 12 months-$2.42$0.25
Revenue growth, year on year-0.5%18.8%
Revenue growth a year, past-7.5%over 5 years+20.4%over 5 years
EPS growth a year, past––

Margins and returns on capital

INTCOPRX
Margins and returns on capital
Gross margin39.9%78.1%
Operating margin2.9%12.2%
Net margin-20.1%5.3%
ROIC0.9%4.6%
ROE-11.3%3.9%

Balance sheet

INTCOPRX
Balance sheet
Cash$54.0B$22M
Total debt$50.1B–
Net debt / EBITDA-0.3–
Interest cover1.5×3.1×

Dividends and buybacks

INTCOPRX
Dividends and buybacks
Dividend yield––
Dividend per share, 12 months––
Dividend growth a year, past––
Buyback yield––
Shareholder yield––

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: INTC or OPRX

Didn't find what you were looking for?

Ask us
Which is bigger, Intel or OptimizeRx?

By market value, Intel ($294B) is about 2,365.1 times OptimizeRx ($124M), at today's prices.

How did INTC and OPRX stock do over the last 10 years?

Since November 16, 2016, INTC's price moved +58.8% and OPRX's +125.2%. With dividends: INTC +94.5% (+6.9% a year), OPRX +125.2% (+8.5% a year). Past returns do not predict future ones.

Which pays the higher dividend, INTC or OPRX?

Neither paid a dividend over the last twelve months: Intel and OptimizeRx return money to shareholders, if they do, in other ways, such as buybacks.

Which has the higher profit margins, Intel or OptimizeRx?

Over the last twelve months, the net margin was -20.1% for Intel and 5.3% for OptimizeRx, and the operating margin 2.9% and 12.2%. Revenue was $59.9B and $94M.

Which is the better investment, Intel or OptimizeRx?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.